Cancer of Unknown Primary, NOS — Trials

Cancer of Unknown Primary, NOS — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Erasmus Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07434180	Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary(Lu-FAP CUP)	not yet recruiting	Phase 2	20	Peter MacCallum Cancer Centre, AustraliaOTHER	1	Feb 25, 2026	clinicaltrials
NCT06869174	Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary	not yet recruiting	Phase 2	50	Zhiguo Luo, MD, PhDOTHER	1	Mar 12, 2025	clinicaltrials